Compounds and methods for treating diseases mediated by a P2X
3
and/or a P2X
2/3
receptor antagonist, the compounds being of formula (I):
wherein D, X, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
and R
8
are as defined herein.
The present invention relates to compounds of Formula (I):
1
wherein A
1
is methylene, ethylene or propylene group and A
2
is N or CR
5
, or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HCV NS3 protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
Amino-substituted<i>para-</i>Benzoquinones as Potential Herbicides
作者:Amalyn Nain-Perez、Luiz C. A. Barbosa、Marcelo C. Picanço、Samuele Giberti、Giuseppe Forlani
DOI:10.1002/cbdv.201500340
日期:2016.8
ability of benzoquinone derivatives to interfere with the light‐driven ferricyanide reduction by isolated spinach chloroplasts was evaluated. Some substances showed a moderate effect as uncouplers, but no relationship was found between this property and their biological activity, indicating that the herbicidal effect is not associated with the inhibition of the photosynthetic electron transport chain
Peptide inhibitors of hepatitis C virus NS3 protein
申请人:——
公开号:US20020177725A1
公开(公告)日:2002-11-28
This invention relates to a novel class of peptides having the Formula (I):
1
Which are useful as serine protease inhibitors, and more particularly as Hepatitis C virus(HCV) NS3 protease inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same in the treatment of HCV infection.
[EN] ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE<br/>[FR] INHIBITEURS D'ALPHA-CETOAMIDES DE LA PROTEASE NS3 DU VIRUS DE L'HEPATITE C
申请人:DU PONT PHARM CO
公开号:WO2001040262A1
公开(公告)日:2001-06-07
The present invention relates to ketoamide and ketoester compounds of Formula (I): where W is -NH- or -O-, or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HCV NS3 protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.